The global Non-biodegradable Implantable Drug Delivery System market size is predicted to grow from US$ 1326 million in 2025 to US$ 1905 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.
A biodegradable implantable drug delivery system is a medical device or drug delivery system that is made of biodegradable materials and can be implanted into the human or animal body for sustained release of drugs or therapeutic substances, and then gradually decomposes into biodegradable materials. Absorbed components that are ultimately completely metabolized or eliminated by the organism
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The 鈥淣on-biodegradable Implantable Drug Delivery System Industry Forecast鈥� looks at past sales and reviews total world Non-biodegradable Implantable Drug Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-biodegradable Implantable Drug Delivery System sales for 2025 through 2031. With Non-biodegradable Implantable Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-biodegradable Implantable Drug Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Non-biodegradable Implantable Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-biodegradable Implantable Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Non-biodegradable Implantable Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-biodegradable Implantable Drug Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-biodegradable Implantable Drug Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-biodegradable Implantable Drug Delivery System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Subcutaneous Implant Type
Injection Implant Type
Other
Segmentation by Application:
Tumor
Ophthalmology
Reproductive Health
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbive
TerSera Therapeutics
Azurity
Simcere
Intersect ENT
Clinuvel
Innocoll Biotherapeutics
Alimera Sciences
Organon
ENDO Pharma
Linhua Medical
BD
Braun
AngioDynamics
Smiths Medical
Teleflex
Cook Medical
Fresenius
Vygon
PFM Medical
Districlass
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-biodegradable Implantable Drug Delivery System market?
What factors are driving Non-biodegradable Implantable Drug Delivery System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-biodegradable Implantable Drug Delivery System market opportunities vary by end market size?
How does Non-biodegradable Implantable Drug Delivery System break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-biodegradable Implantable Drug Delivery System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Non-biodegradable Implantable Drug Delivery System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Non-biodegradable Implantable Drug Delivery System by Country/Region, 2020, 2024 & 2031
2.2 Non-biodegradable Implantable Drug Delivery System Segment by Type
2.2.1 Subcutaneous Implant Type
2.2.2 Injection Implant Type
2.2.3 Other
2.3 Non-biodegradable Implantable Drug Delivery System Sales by Type
2.3.1 Global Non-biodegradable Implantable Drug Delivery System Sales Market Share by Type (2020-2025)
2.3.2 Global Non-biodegradable Implantable Drug Delivery System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Non-biodegradable Implantable Drug Delivery System Sale Price by Type (2020-2025)
2.4 Non-biodegradable Implantable Drug Delivery System Segment by Application
2.4.1 Tumor
2.4.2 Ophthalmology
2.4.3 Reproductive Health
2.4.4 Other
2.5 Non-biodegradable Implantable Drug Delivery System Sales by Application
2.5.1 Global Non-biodegradable Implantable Drug Delivery System Sale Market Share by Application (2020-2025)
2.5.2 Global Non-biodegradable Implantable Drug Delivery System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Non-biodegradable Implantable Drug Delivery System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Non-biodegradable Implantable Drug Delivery System Breakdown Data by Company
3.1.1 Global Non-biodegradable Implantable Drug Delivery System Annual Sales by Company (2020-2025)
3.1.2 Global Non-biodegradable Implantable Drug Delivery System Sales Market Share by Company (2020-2025)
3.2 Global Non-biodegradable Implantable Drug Delivery System Annual Revenue by Company (2020-2025)
3.2.1 Global Non-biodegradable Implantable Drug Delivery System Revenue by Company (2020-2025)
3.2.2 Global Non-biodegradable Implantable Drug Delivery System Revenue Market Share by Company (2020-2025)
3.3 Global Non-biodegradable Implantable Drug Delivery System Sale Price by Company
3.4 Key Manufacturers Non-biodegradable Implantable Drug Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-biodegradable Implantable Drug Delivery System Product Location Distribution
3.4.2 Players Non-biodegradable Implantable Drug Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Non-biodegradable Implantable Drug Delivery System by Geographic Region
4.1 World Historic Non-biodegradable Implantable Drug Delivery System Market Size by Geographic Region (2020-2025)
4.1.1 Global Non-biodegradable Implantable Drug Delivery System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Non-biodegradable Implantable Drug Delivery System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Non-biodegradable Implantable Drug Delivery System Market Size by Country/Region (2020-2025)
4.2.1 Global Non-biodegradable Implantable Drug Delivery System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Non-biodegradable Implantable Drug Delivery System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Non-biodegradable Implantable Drug Delivery System Sales Growth
4.4 APAC Non-biodegradable Implantable Drug Delivery System Sales Growth
4.5 Europe Non-biodegradable Implantable Drug Delivery System Sales Growth
4.6 Middle East & Africa Non-biodegradable Implantable Drug Delivery System Sales Growth
5 Americas
5.1 Americas Non-biodegradable Implantable Drug Delivery System Sales by Country
5.1.1 Americas Non-biodegradable Implantable Drug Delivery System Sales by Country (2020-2025)
5.1.2 Americas Non-biodegradable Implantable Drug Delivery System Revenue by Country (2020-2025)
5.2 Americas Non-biodegradable Implantable Drug Delivery System Sales by Type (2020-2025)
5.3 Americas Non-biodegradable Implantable Drug Delivery System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-biodegradable Implantable Drug Delivery System Sales by Region
6.1.1 APAC Non-biodegradable Implantable Drug Delivery System Sales by Region (2020-2025)
6.1.2 APAC Non-biodegradable Implantable Drug Delivery System Revenue by Region (2020-2025)
6.2 APAC Non-biodegradable Implantable Drug Delivery System Sales by Type (2020-2025)
6.3 APAC Non-biodegradable Implantable Drug Delivery System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-biodegradable Implantable Drug Delivery System by Country
7.1.1 Europe Non-biodegradable Implantable Drug Delivery System Sales by Country (2020-2025)
7.1.2 Europe Non-biodegradable Implantable Drug Delivery System Revenue by Country (2020-2025)
7.2 Europe Non-biodegradable Implantable Drug Delivery System Sales by Type (2020-2025)
7.3 Europe Non-biodegradable Implantable Drug Delivery System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-biodegradable Implantable Drug Delivery System by Country
8.1.1 Middle East & Africa Non-biodegradable Implantable Drug Delivery System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Non-biodegradable Implantable Drug Delivery System Revenue by Country (2020-2025)
8.2 Middle East & Africa Non-biodegradable Implantable Drug Delivery System Sales by Type (2020-2025)
8.3 Middle East & Africa Non-biodegradable Implantable Drug Delivery System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-biodegradable Implantable Drug Delivery System
10.3 Manufacturing Process Analysis of Non-biodegradable Implantable Drug Delivery System
10.4 Industry Chain Structure of Non-biodegradable Implantable Drug Delivery System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-biodegradable Implantable Drug Delivery System Distributors
11.3 Non-biodegradable Implantable Drug Delivery System Customer
12 World Forecast Review for Non-biodegradable Implantable Drug Delivery System by Geographic Region
12.1 Global Non-biodegradable Implantable Drug Delivery System Market Size Forecast by Region
12.1.1 Global Non-biodegradable Implantable Drug Delivery System Forecast by Region (2026-2031)
12.1.2 Global Non-biodegradable Implantable Drug Delivery System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Non-biodegradable Implantable Drug Delivery System Forecast by Type (2026-2031)
12.7 Global Non-biodegradable Implantable Drug Delivery System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Abbive
13.1.1 Abbive Company Information
13.1.2 Abbive Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.1.3 Abbive Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbive Main Business Overview
13.1.5 Abbive Latest Developments
13.2 TerSera Therapeutics
13.2.1 TerSera Therapeutics Company Information
13.2.2 TerSera Therapeutics Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.2.3 TerSera Therapeutics Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 TerSera Therapeutics Main Business Overview
13.2.5 TerSera Therapeutics Latest Developments
13.3 Azurity
13.3.1 Azurity Company Information
13.3.2 Azurity Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.3.3 Azurity Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Azurity Main Business Overview
13.3.5 Azurity Latest Developments
13.4 Simcere
13.4.1 Simcere Company Information
13.4.2 Simcere Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.4.3 Simcere Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Simcere Main Business Overview
13.4.5 Simcere Latest Developments
13.5 Intersect ENT
13.5.1 Intersect ENT Company Information
13.5.2 Intersect ENT Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.5.3 Intersect ENT Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Intersect ENT Main Business Overview
13.5.5 Intersect ENT Latest Developments
13.6 Clinuvel
13.6.1 Clinuvel Company Information
13.6.2 Clinuvel Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.6.3 Clinuvel Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Clinuvel Main Business Overview
13.6.5 Clinuvel Latest Developments
13.7 Innocoll Biotherapeutics
13.7.1 Innocoll Biotherapeutics Company Information
13.7.2 Innocoll Biotherapeutics Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.7.3 Innocoll Biotherapeutics Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Innocoll Biotherapeutics Main Business Overview
13.7.5 Innocoll Biotherapeutics Latest Developments
13.8 Alimera Sciences
13.8.1 Alimera Sciences Company Information
13.8.2 Alimera Sciences Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.8.3 Alimera Sciences Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Alimera Sciences Main Business Overview
13.8.5 Alimera Sciences Latest Developments
13.9 Organon
13.9.1 Organon Company Information
13.9.2 Organon Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.9.3 Organon Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Organon Main Business Overview
13.9.5 Organon Latest Developments
13.10 ENDO Pharma
13.10.1 ENDO Pharma Company Information
13.10.2 ENDO Pharma Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.10.3 ENDO Pharma Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 ENDO Pharma Main Business Overview
13.10.5 ENDO Pharma Latest Developments
13.11 Linhua Medical
13.11.1 Linhua Medical Company Information
13.11.2 Linhua Medical Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.11.3 Linhua Medical Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Linhua Medical Main Business Overview
13.11.5 Linhua Medical Latest Developments
13.12 BD
13.12.1 BD Company Information
13.12.2 BD Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.12.3 BD Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 BD Main Business Overview
13.12.5 BD Latest Developments
13.13 Braun
13.13.1 Braun Company Information
13.13.2 Braun Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.13.3 Braun Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Braun Main Business Overview
13.13.5 Braun Latest Developments
13.14 AngioDynamics
13.14.1 AngioDynamics Company Information
13.14.2 AngioDynamics Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.14.3 AngioDynamics Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 AngioDynamics Main Business Overview
13.14.5 AngioDynamics Latest Developments
13.15 Smiths Medical
13.15.1 Smiths Medical Company Information
13.15.2 Smiths Medical Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.15.3 Smiths Medical Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Smiths Medical Main Business Overview
13.15.5 Smiths Medical Latest Developments
13.16 Teleflex
13.16.1 Teleflex Company Information
13.16.2 Teleflex Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.16.3 Teleflex Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Teleflex Main Business Overview
13.16.5 Teleflex Latest Developments
13.17 Cook Medical
13.17.1 Cook Medical Company Information
13.17.2 Cook Medical Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.17.3 Cook Medical Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Cook Medical Main Business Overview
13.17.5 Cook Medical Latest Developments
13.18 Fresenius
13.18.1 Fresenius Company Information
13.18.2 Fresenius Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.18.3 Fresenius Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Fresenius Main Business Overview
13.18.5 Fresenius Latest Developments
13.19 Vygon
13.19.1 Vygon Company Information
13.19.2 Vygon Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.19.3 Vygon Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Vygon Main Business Overview
13.19.5 Vygon Latest Developments
13.20 PFM Medical
13.20.1 PFM Medical Company Information
13.20.2 PFM Medical Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.20.3 PFM Medical Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 PFM Medical Main Business Overview
13.20.5 PFM Medical Latest Developments
13.21 Districlass
13.21.1 Districlass Company Information
13.21.2 Districlass Non-biodegradable Implantable Drug Delivery System Product Portfolios and Specifications
13.21.3 Districlass Non-biodegradable Implantable Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Districlass Main Business Overview
13.21.5 Districlass Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
